Bath & Body Works (NYSE:BBWI) Releases FY 2025 Earnings Guidance

Bath & Body Works (NYSE:BBWI) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 3.250-3.600 for the period, compared to the consensus estimate of 3.650. The company issued revenue guidance of $7.4 billion-$7.5 billion, compared to the consensus revenue estimate of $7.5 billion. Bath & Body Works also updated its Q1 2025 guidance to 0.360-0.430 EPS.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the company. TD Cowen increased their price objective on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Cowen reaffirmed a “buy” rating on shares of Bath & Body Works in a report on Thursday. Argus reiterated a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Robert W. Baird boosted their price objective on Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a report on Friday. Finally, Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $42.00 to $48.00 in a research note on Friday, January 10th. Five research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $45.38.

Bath & Body Works Stock Up 0.9 %

Shares of NYSE:BBWI traded up $0.31 during trading on Friday, reaching $36.17. 3,136,003 shares of the company traded hands, compared to its average volume of 3,663,079. Bath & Body Works has a 1-year low of $26.20 and a 1-year high of $52.99. The firm has a market cap of $7.83 billion, a P/E ratio of 8.82, a price-to-earnings-growth ratio of 0.92 and a beta of 1.83. The firm has a fifty day simple moving average of $37.76 and a 200 day simple moving average of $34.08.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, research analysts anticipate that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date is Friday, February 21st. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Bath & Body Works declared that its Board of Directors has approved a stock buyback program on Thursday, February 27th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 6.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.